Healthcare data analytics solutions are the platforms and datasets that turn healthcare information into something you can act on. Healthcare data analytics services are the human layer around them: cleaning, enrichment, custom research, and managed work that a platform alone doesn't do. Most buyers need some mix of both, and most comparison guides won't help you pick, because they're written for hospitals evaluating clinical tools.
If you sell into US healthcare, your evaluation criteria are almost entirely different. A hospital analytics buyer cares about EHR integration, clinical validation, and quality measure reporting. You care about whether the data can tell you which account is worth a call on Tuesday and who inside it can actually sign.
Generic evaluation advice sends you hunting for things you don't need. Clinical validation, HL7 and FHIR interoperability, and population health modeling are real requirements for a health system. They tell you nothing about whether a dataset will help you hit a number.
This is the checklist for the second job. It names criteria, not vendors, because the right answer depends on what you sell and to whom.
Solutions or services: which do you actually need?
Worth settling early, because buying the wrong shape wastes a year.
A solution is the product: a platform, a dataset, an API, a feed into your CRM. You operate it. Good when you have a repeatable process, someone who owns the data internally, and enough volume to justify a seat-based cost.
A service is people doing the work: custom account research, list building, CRM cleanup, enrichment projects, ongoing data stewardship. Good when the question changes every quarter, when your team is small, or when the problem is a one-time mess rather than an ongoing need.
The common mistake is buying a platform to solve what was really a services problem. If your data is badly out of date, a new subscription doesn't fix it. You get a good tool pointed at a bad foundation, and the tool takes the blame.
A useful test: if you can write down the question you'll ask the data every month, buy a solution. If the question is different every time, or you don't know what to ask yet, start with a service.
Talk to Intent.Health →Eight criteria that actually matter
1. Record-level recency, not database refresh rate
Every vendor will tell you how often they refresh. That figure is an average across the whole database, and averages hide the tail. A provider can refresh 90% of records monthly and leave the rest untouched for two years, and the stale 10% may be exactly the accounts you're targeting.
Ask a different question: when was this specific record last verified, and how? If the platform can't show you a verification date per record, the refresh rate is a marketing number.
This matters more in healthcare than almost anywhere else. Provider information changes at an estimated 3% a month, which compounds to roughly a quarter to a third of a database going stale each year.
2. Ownership hierarchy depth
A hospital is rarely an independent buyer. It might be one site inside a health system, owned by an integrated delivery network, purchasing through a group purchasing organization, under a corporate or private equity parent.
Ask the platform to show you a single facility and then walk up the chain. How many levels can it actually resolve? Most datasets stop at one. Stopping at one is the difference between calling a facility manager and calling the person who signs.
3. Decision authority, not just job titles
A title is not authority. "Director of Surgical Services" means different things at a 40-bed rural hospital and a 900-bed academic center, and at neither one does it reliably mean signing power.
Ask how the platform distinguishes the person who uses a product from the person who approves the purchase, and whether that distinction is inferred from a title string or from something more substantive.
4. Change signals, not just current state
A directory tells you what is. Intelligence tells you what moved.
The events that open a buying window are changes: a new service line, a leadership hire, a merger, a facility expansion, a reimbursement or coding shift, a new payment model. Ask what changes the platform detects, how quickly they surface, and whether you can be alerted rather than having to go look.
If the answer is a database you query when you remember to, you're buying a reference book.
Talk to Intent.Health →5. Accuracy, measured and published
Vendors compete on coverage because coverage is easy to measure and easy to win. Bigger number, better slide. Accuracy is expensive to prove and easy to avoid discussing.
Ask how accuracy is measured, on what sample, how often, and whether they'll show you the figure. A vendor who can't answer has probably never measured it.
For context on how hard this is: a peer-reviewed study of physician directories across five large national insurers found address and specialty information inconsistent for more than 80% of physicians, with address consistency ranging from about 16% to 28%. Maintaining those directories costs US physician practices an estimated $2.76 billion a year, and they're still wrong. Anyone claiming near-perfect accuracy at scale is describing an ambition.
6. Where the data comes from
Provenance determines reliability, and different sources fail in different ways.
- Claims data is strong for procedure volumes and referral patterns, but lags by months
- Public filings and registries are authoritative but slow and incomplete
- Self-reported data is current but unverified
- Scraped web data is cheap, wide, and decays fastest
None of these is disqualifying. What matters is whether the vendor will tell you which source backs which field, and whether they blend sources without saying so.
7. Match rate against your existing records
A dataset that won't connect to your CRM is a migration project, not a tool.
Before signing, send a sample of your own records and ask for a match rate. Not their sample. Yours. A vendor confident in their coverage will run it; one who deflects to a curated demo file is telling you something.
8. Usage rights and compliance
Confirm in writing what you're allowed to do with the data, especially for outbound. Requirements vary depending on what you sell and to whom, and can touch CAN-SPAM, state privacy laws like CCPA, and for life sciences companies, Sunshine Act reporting obligations.
Ask specifically: can this be used for outbound email, can it be loaded into your CRM permanently, what happens to your data if you cancel, and who is liable if a record turns out to be wrong.
Talk to Intent.Health →The test that beats every demo
Every demo is run on accounts the vendor knows well. That's not dishonest, it's just how demos work. It also means you learn nothing about the accounts they don't know.
Here's a better evaluation, and it costs you an afternoon:
Take 50 accounts you already know cold. Your existing customers. The ones where you know the org chart, who signed, what they bought, and what changed last year. You have ground truth on these.
Run them through the platform and count the errors.
Most buyers evaluate on accounts they don't know, where they have no way to detect a mistake. Evaluating on accounts you know inverts that. You'll find out in one sitting whether the hierarchy resolves correctly, whether the contacts are current, and whether the signals it reports actually happened.
If a vendor won't let you run your own list during evaluation, that's your answer.
Questions worth asking on the call
- When was this specific record last verified, and by what method?
- Show me this facility's full ownership chain. How many levels up can you go?
- What percentage of records have a verified contact at the decision-making level, not just the site level?
- How do you measure accuracy, and will you share the number?
- Which source backs each field?
- What's your match rate against a sample I provide?
- What changes trigger an alert, and how fast?
- What am I contractually allowed to do with this data for outbound?
- What happens to the records I've enriched if I cancel?
FAQ
What are healthcare data analytics solutions? Platforms, datasets, and tools that turn healthcare information into insight you can act on. For commercial teams, that usually means identifying target accounts, mapping decision makers, and spotting buying signals.
What's the difference between healthcare data analytics solutions and services? A solution is a product you operate yourself, like a platform or data feed. A service is people doing the work for you, such as custom research, CRM cleanup, or ongoing enrichment. Many teams use both.
Should I buy a platform or a service? If you ask the data the same question every month, buy a platform. If the question changes each time, or your existing data is a mess that needs fixing first, start with a service.
What should I look for when evaluating healthcare data? Record-level verification dates, ownership hierarchy depth, decision authority mapping, change signals, published accuracy measurement, clear data provenance, match rate against your own records, and explicit usage rights.
Why does refresh rate matter less than it sounds? Refresh rate is a database-wide average. A vendor can refresh most records frequently while leaving a subset untouched for years. What matters is when your specific target records were last verified.
How fast does healthcare data go out of date? Provider information changes at roughly 3% per month, meaning a significant share of any database is inaccurate within a year unless actively maintained.
How do I test a vendor properly? Run 50 accounts you already know well, such as existing customers, and count the errors. You have ground truth on those, so mistakes are visible. Demos use accounts the vendor already knows.
Is a bigger database better? Not on its own. Coverage is easy for vendors to measure and advertise; accuracy is harder and matters more. A large database full of stale records costs you more time than a smaller accurate one.
The bottom line
Most guides to evaluating healthcare data analytics are written for people buying clinical tools, and their criteria don't transfer. If you're selling into US healthcare, the questions that decide whether a dataset is worth paying for are narrower and more specific: when was this record verified, how far up the ownership chain can you see, who can actually sign, and what changed recently enough to matter.
The vendors worth working with will answer those questions directly and let you test on your own accounts. The ones who steer you back to a curated demo have already told you what you needed to know.
Test it on your accounts.
Talk to Intent.Health →Related case studies
Consumer Health Company CRM Mailability. A global consumer healthcare company raised physician mailability from 47% to over 95% by fixing CRM data decay.
Fortune 100 Pharmaceutical CRM Data Decay. How outdated physician CRM data was quietly turning routine sample shipments into avoidable revenue loss.
GTM Intelligence for a Healthcare AI Company. How installed EHR intelligence was used to personalize outreach and accelerate sales conversations.
